Covid-19 roundup: Pfiz­er li­cens­es its pill to the Med­i­cines Patent Pool; NYC joins states in au­tho­riz­ing boost­ers for all adults ahead of FDA

Fol­low­ing a sim­i­lar deal forged by Mer­ck for its Covid-19 drug mol­nupi­ravir, Pfiz­er on Tues­day agreed to al­low the UN-backed Med­i­cines Patent Pool to li­cense …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER